Recombinant Human TDG Protein，His & SUMO

The study of TDG (thymine DNA glycosylase) recombinant proteins has gained significant attention due to their crucial role in maintaining genomic stability and their implications in various biological processes, including DNA repair and epigenetic regulation. TDG is a DNA glycosylase that specifically recognizes and excises mismatched thymine bases in DNA, which can result from oxidative damage or deamination events. Dysfunction in TDG activity is associated with various diseases, including cancer, emphasizing the need for a deeper understanding of its mechanisms. Moreover, TDG is linked to the regulation of gene expression through its interactions with 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), which are essential for epigenetic modifications. Research has focused on producing recombinant forms of TDG to investigate its structure-function relationships, enzyme kinetics, and interactions with other molecular components. These recombinant proteins enable the exploration of TDG's role in DNA repair pathways and its potential as a therapeutic target. Furthermore, advancements in recombinant protein technology have facilitated the purification and characterization of TDG, allowing for greater insights into its biological functions and its potential applications in biotechnology and medicine. As such, the ongoing research into TDG recombinant proteins is not only pivotal for understanding fundamental biological processes but also holds promise for developing novel therapeutic strategies in treating diseases linked to improper DNA repair mechanisms.